Add to ORKGA letter report issued by the General Accounting Office with an abstract that begins "Pursuant to a congressional request, GAO provided information on the expansion of Medicare beneficiaries' access to prescription drugs, focusing on the: (1) federal drug price discounts available to federal and nonfederal purchasers and the size of those discounts; and (2) potential effects that extending such discounts to nonfederal purchasers may have on outpatient drug prices paid by federal and nonfederal purchasers.
A letter report issued by the General Accounting Office with an abstract that begins "While prescrip...
A letter report issued by the Government Accountability Office with an abstract that begins "The Hea...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
Testimony issued by the Government Accountability Office with an abstract that begins "Several feder...
Testimony issued by the Government Accountability Office with an abstract that begins "Rising prescr...
A letter report issued by the Government Accountability Office with an abstract that begins "Prescri...
Testimony issued by the Government Accountability Office with an abstract that begins "Millions of i...
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
A letter report issued by the Government Accountability Office with an abstract that begins "The gro...
Correspondence issued by the Government Accountability Office with an abstract that begins "This rep...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
A letter report issued by the General Accounting Office with an abstract that begins "Although physi...
A letter report issued by the General Accounting Office with an abstract that begins "While prescrip...
A letter report issued by the Government Accountability Office with an abstract that begins "The Hea...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
Testimony issued by the Government Accountability Office with an abstract that begins "Several feder...
Testimony issued by the Government Accountability Office with an abstract that begins "Rising prescr...
A letter report issued by the Government Accountability Office with an abstract that begins "Prescri...
Testimony issued by the Government Accountability Office with an abstract that begins "Millions of i...
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
A letter report issued by the Government Accountability Office with an abstract that begins "The gro...
Correspondence issued by the Government Accountability Office with an abstract that begins "This rep...
Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...
A letter report issued by the General Accounting Office with an abstract that begins "Although physi...
A letter report issued by the General Accounting Office with an abstract that begins "While prescrip...
A letter report issued by the Government Accountability Office with an abstract that begins "The Hea...
Correspondence issued by the Government Accountability Office with an abstract that begins "Spending...